SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067113
Filing Date
2023-08-14
Accepted
2023-08-14 16:30:58
Documents
81
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_abvcbio.htm   iXBRL 10-Q 1125665
2 CERTIFICATION f10q0623ex31-1_abvcbio.htm EX-31.1 11227
3 CERTIFICATION f10q0623ex31-2_abvcbio.htm EX-31.2 11650
4 CERTIFICATION f10q0623ex32-1_abvcbio.htm EX-32.1 4774
5 CERTIFICATION f10q0623ex32-2_abvcbio.htm EX-32.2 4680
  Complete submission text file 0001213900-23-067113.txt   6686536

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20230630.xsd EX-101.SCH 86766
7 XBRL CALCULATION FILE abvc-20230630_cal.xml EX-101.CAL 40567
8 XBRL DEFINITION FILE abvc-20230630_def.xml EX-101.DEF 323136
9 XBRL LABEL FILE abvc-20230630_lab.xml EX-101.LAB 641078
10 XBRL PRESENTATION FILE abvc-20230630_pre.xml EX-101.PRE 338968
75 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_abvcbio_htm.xml XML 786051
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 231170961
SIC: 2834 Pharmaceutical Preparations